Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SUCR1 antagonists(succinate receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H35N7O6 |
InChIKeyIRYPJZWXCBPWNC-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Preclinical | DK | 15 Jun 2023 | |
Inflammatory Bowel Diseases | Preclinical | DK | 15 Jun 2023 | |
Rheumatoid Arthritis | Preclinical | DK | 15 Jun 2023 |